Podcast
Questions and Answers
Which of the following is NOT a cause of neuronal damage in neurodegenerative diseases?
Which of the following is NOT a cause of neuronal damage in neurodegenerative diseases?
- Increased neuronal regeneration (correct)
- Excessive excitotoxicity
- Apoptosis
- Oxidative stress
Dopaminergic neurons can regenerate after damage in the central nervous system.
Dopaminergic neurons can regenerate after damage in the central nervous system.
False (B)
Name one neurodegenerative disease mentioned.
Name one neurodegenerative disease mentioned.
Parkinson's disease
The nigrostriatal tract plays a key role in regulating _____ by releasing dopamine.
The nigrostriatal tract plays a key role in regulating _____ by releasing dopamine.
Match the following dopaminergic pathways with their primary functions:
Match the following dopaminergic pathways with their primary functions:
What is the primary reason large doses of L-dopa are required?
What is the primary reason large doses of L-dopa are required?
Carbidopa and Benserazide are unable to cross the blood-brain barrier.
Carbidopa and Benserazide are unable to cross the blood-brain barrier.
What is the effect of combining L-dopa with Carbidopa?
What is the effect of combining L-dopa with Carbidopa?
The enzyme that breaks down L-dopa in the periphery is called ______.
The enzyme that breaks down L-dopa in the periphery is called ______.
Match the following drugs with their functions:
Match the following drugs with their functions:
Which metabolite is produced when L-dopa is broken down by COMT?
Which metabolite is produced when L-dopa is broken down by COMT?
The effectiveness of the L-dopa/Carbidopa combination does not decline over time.
The effectiveness of the L-dopa/Carbidopa combination does not decline over time.
What is the primary purpose of using carbidopa in combination with L-dopa?
What is the primary purpose of using carbidopa in combination with L-dopa?
Entacapone is a central COMT inhibitor.
Entacapone is a central COMT inhibitor.
What phenomenon describes the fluctuations in motor response due to short half-life of L-dopa?
What phenomenon describes the fluctuations in motor response due to short half-life of L-dopa?
The combination treatment of L-dopa + Carbidopa + ________ is commonly used for Parkinson's disease.
The combination treatment of L-dopa + Carbidopa + ________ is commonly used for Parkinson's disease.
Match the following treatments with their mechanism:
Match the following treatments with their mechanism:
What is a significant side effect of Tolcapone?
What is a significant side effect of Tolcapone?
Increasing the frequency of L-dopa doses can help manage the wear-off phenomenon.
Increasing the frequency of L-dopa doses can help manage the wear-off phenomenon.
What happens with chronic use of L-dopa regarding the dopaminergic neurons?
What happens with chronic use of L-dopa regarding the dopaminergic neurons?
The gradual fading of improvement gained from a dose of levodopa is known as the __________ phenomenon.
The gradual fading of improvement gained from a dose of levodopa is known as the __________ phenomenon.
What is the effect of high doses of catecholamines on the pupil?
What is the effect of high doses of catecholamines on the pupil?
Levodopa is effective in patients who have not responded to dopamine receptor agonists.
Levodopa is effective in patients who have not responded to dopamine receptor agonists.
What is the primary concern with administering nonselective MAO inhibitors while on levodopa?
What is the primary concern with administering nonselective MAO inhibitors while on levodopa?
Bromocriptine is derived from _______.
Bromocriptine is derived from _______.
Match the drug to its effect:
Match the drug to its effect:
Which of the following is an adverse effect common to both levodopa and dopamine agonists?
Which of the following is an adverse effect common to both levodopa and dopamine agonists?
Dopamine receptor agonists are known to significantly reduce motor fluctuations in advanced Parkinson's disease without the need for L-dopa.
Dopamine receptor agonists are known to significantly reduce motor fluctuations in advanced Parkinson's disease without the need for L-dopa.
What is the main advantage of dopamine agonists over levodopa?
What is the main advantage of dopamine agonists over levodopa?
Prolonged use of _______ may cause mental conditions to worsen in psychiatric patients.
Prolonged use of _______ may cause mental conditions to worsen in psychiatric patients.
Flashcards
What is the nigrostriatal tract?
What is the nigrostriatal tract?
The nigrostriatal tract is a pathway in the brain that involves the release of dopamine from the substantia nigra to the striatum. This release regulates movement by inhibiting GABA-ergic and cholinergic neurons.
What is dopamine's role in the brain?
What is dopamine's role in the brain?
Dopamine is a neurotransmitter in the brain that plays an essential role in various functions, including movement, cognition, and emotions. It is released from specific pathways, including the nigrostriatal tract involved in movement regulation.
What are neurodegenerative diseases?
What are neurodegenerative diseases?
Neurodegenerative diseases are characterized by progressive damage to neurons in certain brain areas. This damage can result from various factors like excessive excitotoxicity, stroke, oxidative stress, or apoptosis.
What are antiparkinsonian drugs?
What are antiparkinsonian drugs?
Signup and view all the flashcards
Why are neurodegenerative diseases difficult to treat?
Why are neurodegenerative diseases difficult to treat?
Signup and view all the flashcards
What is L-dopa?
What is L-dopa?
Signup and view all the flashcards
What does Dopa decarboxylase do?
What does Dopa decarboxylase do?
Signup and view all the flashcards
How do Carbidopa and Benserazide work?
How do Carbidopa and Benserazide work?
Signup and view all the flashcards
What is COMT?
What is COMT?
Signup and view all the flashcards
What do Entacapone and Tolcapone do?
What do Entacapone and Tolcapone do?
Signup and view all the flashcards
Why are high doses of L-dopa needed?
Why are high doses of L-dopa needed?
Signup and view all the flashcards
What is the most common treatment for Parkinson's?
What is the most common treatment for Parkinson's?
Signup and view all the flashcards
What is Carbidopa?
What is Carbidopa?
Signup and view all the flashcards
What is Entacapone?
What is Entacapone?
Signup and view all the flashcards
What is Stalevo?
What is Stalevo?
Signup and view all the flashcards
What is the "on-off" phenomenon?
What is the "on-off" phenomenon?
Signup and view all the flashcards
What is the "wear-off" phenomenon?
What is the "wear-off" phenomenon?
Signup and view all the flashcards
How can we manage the "on-off" phenomenon?
How can we manage the "on-off" phenomenon?
Signup and view all the flashcards
What causes L-dopa degradation?
What causes L-dopa degradation?
Signup and view all the flashcards
How does L-dopa reach the brain?
How does L-dopa reach the brain?
Signup and view all the flashcards
Why does L-dopa's effectiveness diminish over time?
Why does L-dopa's effectiveness diminish over time?
Signup and view all the flashcards
Dopamine's role in Parkinson's disease
Dopamine's role in Parkinson's disease
Signup and view all the flashcards
How does Levodopa work?
How does Levodopa work?
Signup and view all the flashcards
What do MAO inhibitors do?
What do MAO inhibitors do?
Signup and view all the flashcards
How do dopamine agonists work?
How do dopamine agonists work?
Signup and view all the flashcards
What are the side effects of Levodopa?
What are the side effects of Levodopa?
Signup and view all the flashcards
Bromocriptine: A dopamine agonist
Bromocriptine: A dopamine agonist
Signup and view all the flashcards
Side effects of Bromocriptine
Side effects of Bromocriptine
Signup and view all the flashcards
Antipsychotics and Parkinson's
Antipsychotics and Parkinson's
Signup and view all the flashcards
Vitamin B6 and Levodopa
Vitamin B6 and Levodopa
Signup and view all the flashcards
Study Notes
Drugs Affecting the Central Nervous System
- Neurodegenerative diseases involve neuronal damage in specific brain regions.
- Causes include excessive excitotoxicity (excess glutamate), stroke, head trauma, oxidative stress (increased reactive oxygen species), and apoptosis (programmed cell death).
- Neurodegenerative diseases are difficult to treat as CNS neurons cannot regenerate once damaged. Treatment is therefore symptomatic.
- Examples of neurodegenerative diseases: Parkinson's, Alzheimer's, Huntington's, and Multiple sclerosis.
Dopaminergic Pathways
- Dopamine (DA) is a precursor to norepinephrine (NE) in noradrenergic pathways.
- It's a neurotransmitter in:
- Nigrostriatal tract: DA-releasing neurons project to the striatum, regulating movement by inhibiting GABA-ergic and cholinergic neurons.
- Mesolimbic-mesocortical tracts: DA-releasing neurons projecting to limbic and cortical structures regulate cognitive functions.
- Tuberoinfundibular tract: DA-releasing neurons from the hypothalamus regulate prolactin levels in the anterior pituitary.
- Chemoreceptor trigger zone: DA receptor activation in the medulla increases vomiting.
Parkinson's Disease
- Parkinson's is a progressive neurological disorder of movement, second only to Alzheimer's disease in frequency.
- Characterized by four cardinal motor features: resting tremors, muscular rigidity, bradykinesia (slow movement), and abnormal gait.
- Occurs primarily in individuals over 65.
- Etiology involves neurodegeneration in inhibitory dopaminergic neurons relative to excitatory cholinergic neurons in the nigrostriatal tract.
- Imbalance between these causes the symptoms in Parkinson's disease.
Parkinson's Disease Classification
- Primary (idiopathic): More than 80% dopaminergic neuron degeneration in the substantia nigra leading to dopamine deficiency and increased acetylcholine.
- Secondary (atypical): Often due to imbalances between acetylcholine and dopamine, including:
- Vascular Parkinsonism (Small vessel cerebral ischemia)
- Post-traumatic
- Toxin-induced
- Infectious
- Drug-induced (e.g., antipsychotics)
Treatment of Parkinson's Disease
- Goal: Restoring the balance between acetylcholine and dopamine in the basal ganglia.
- Treatment is symptomatic (temporary relief) and does not prevent disease progression.
- Dopaminergic drugs: Levodopa (L-dopa) is the most common, converting to dopamine in the brain. Peripheral decarboxylase inhibitors (e.g., carbidopa) decrease peripheral dopamine, increasing levodopa reaching the brain.
- Dopamine receptor agonists: Mimic dopamine's function, used in early stages or along with levodopa.
- COMT inhibitors: (e.g. Entacapone) Prevent the breakdown of levodopa.
- Anticholinergic drugs: Help reduce acetylcholine overstimulation, though not as effective as levodopa.
Additional Details
- On-off phenomenon: Fluctuations in levodopa's effect, causing periods of improved and impaired movement.
- Dyskinesias: Involuntary movements, often a long-term consequence of levodopa therapy.
- Adverse Effects: Levodopa may cause nausea, vomiting, dyskinesia, postural hypotension, and confusion.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
This quiz explores the impact of drugs on central nervous system functions, focusing on neurodegenerative diseases and dopaminergic pathways. Participants will learn about causes of neuronal damage, examples of diseases, and the role of dopamine in regulating movement and cognition.